31
311390.KQ Neo Cremar Co. Ltd
- Market cap
- KRW 27.3B
- P/E
- 12.0x
- P/B
- 0.37x
- ROE
- 4.9%
- Dividend yield
- 5.63%
- Fundamental score
- 3.2/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 311390.KQ undervalued?
Graham number311390.KQ trades 55.7% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Neo Cremar Co. Ltd fundamental analysis
15 of 22 checks passedROE 0/2
Low return on equity (4.9%), below 10%.
ROA 1/1
Return on assets (1.9%) is above the industry median (1.4%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (406.4%) is above the 5-year average (4.6% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (406.4%) is above the industry median (1.8%).
Revenue Growth 2/2
Revenue grew 45.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.1%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 14.3x against interest expense, well covered.
PE vs Market 0/1
PE (12.0x) is above the market median (11.3x).
PE vs Industry 0/1
PE (12.0x) is above the industry median (11.4x).
PBV 1/1
Price to book (0.4x) is below the industry median (0.9x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 4.4, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 2.60, above 1.
Dividend Yield 2/2
Dividend yield (5.6%) is in the top 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 51.5%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Neo Cremar Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Neo Cremar Co. Ltd
Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products. It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business. Neo Cremar Co., Ltd. was founded in 1999 and is headquartered in Seoul, South …
Full company profileNeo Cremar Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Neo Cremar Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 14.4B | 12.0B | 21.7B | 19.8B | 29.8B | 29.9B | 26.7B | 24.9B | 40.3B | 81.9B | 83.9B |
| Gross Profit | 4.56B | 3.71B | 6.06B | 4.55B | 7.89B | 8.02B | 6.75B | 5.70B | 11.5B | 29.6B | 33.3B |
| Operating Income | 1.89B | 1.23B | 3.27B | 665M | 1.26B | 1.37B | 1.60B | -4.93B | -2.75B | 5.41B | 8.40B |
| EBITDA | - | - | - | - | - | - | 159M | -3.83B | 4.44B | 14.8B | 26.5B |
| Net Income | 1.62B | 1.16B | 3.56B | 1.03B | 1.39B | 1.84B | -770M | -4.96B | 589M | 2.98B | 3.63B |
| EPS | 223 | 159 | 491 | 141 | 189 | 251 | -81 | -622 | 47 | 237 | 289 |
| Balance Sheet | |||||||||||
| Total Assets | 18.4B | 25.3B | 32.3B | 47.2B | 49.2B | 51.3B | 78.4B | 71.1B | 178B | 182B | 189B |
| Total Liabilities | 3.90B | 16.9B | 9.14B | 9.50B | 9.51B | 9.72B | 29.6B | 32.3B | 108B | 35.5B | 39.4B |
| Shareholders' Equity | 14.5B | 8.40B | 23.1B | 37.7B | 39.7B | 41.6B | 48.7B | 38.9B | 70.8B | 73.5B | 74.3B |
| Cash & Short-term Investments | 7.94B | 7.17B | 7.93B | 12.5B | 13.4B | 15.1B | 24.0B | 30.1B | 41.4B | 33.0B | 20.3B |
| Total Debt | 1.06B | 13.1B | 6.29B | 6.06B | 6.60B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.47B | 656M | 4.02B | -1.01B | 1.83B | 1.86B | -351M | 2.27B | 1.09B | 15.7B | 17.1B |
| Capital Expenditure | 1.36B | 7.77B | 7.10B | 6.82B | 1.32B | 405M | 387M | 889M | 751M | 769M | 1.51B |
| Free Cash Flow | - | - | - | - | 429M | 1.26B | -923M | 1.38B | 343M | 14.9B | 15.6B |
| Ratios | |||||||||||
| ROE | 11.1% | 13.8% | 15.4% | 2.7% | 3.5% | 4.4% | -1.6% | -12.8% | 0.8% | 4.1% | 4.9% |
| ROA | 8.8% | 4.6% | 11.0% | 2.2% | 2.8% | 3.6% | -1.0% | -7.0% | 0.3% | 1.6% | 1.9% |
| Net Profit Margin | 11.2% | 9.6% | 16.4% | 5.2% | 4.6% | 6.1% | -2.9% | -19.9% | 1.5% | 3.6% | 4.3% |
| Debt to Equity | 0.07x | 1.56x | 0.27x | 0.16x | 0.17x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Neo Cremar Co. Ltd dividends
- Dividend yield
- 5.63%
- Forward dividend
- 50.00 KRW
- Payout ratio
- 51.5%
- Ex-dividend date
- Mar 30, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | KRW 1.54B | 122 | 51.5% |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Neo Cremar Co. Ltd
- Insiders 44.88%
- Institutions 0.00%
- Public & others 55.12%
- Shares outstanding 12.6M
- Free float 6.41M
Neo Cremar Co. Ltd company profile
- Company name
- Neo Cremar Co. Ltd
- Ticker
- 311390.KQ
- Exchange
- KOSDAQ
- Sector
- Basic Materials
- Industry
- Oil, Gas & Consumable Fuels
- Employees
- 64
- Fiscal year end
- December
- Address
- 7, Dosandaero 89-gil, Seoul, South Korea, 05836
- Phone
- 82 2 401 4088
- Website
- cremar.co.kr
About Neo Cremar Co. Ltd
Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products. It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business. Neo Cremar Co., Ltd. was founded in 1999 and is headquartered in Seoul, South Korea.
Neo Cremar Co. Ltd management
1- Mr. Joon-Woo LeeDeputy Chair & Co-CEO · born 1963